CAMK2N1 - calcium/calmodulin dependent protein kinase II inhibitor 1 Gene
Also Known as PRO1489
Species: Homo sapiens
About CAMK2N1
This gene has 2 transcripts (splice variants), 183 orthologues and 1 paralogue. Broad expression in brain (RPKM 113.3), colon (RPKM 48.8) and 15 other tissues.
Summary
Enables calcium-dependent protein kinase inhibitor activity and protein kinase binding activity. Involved in several processes, including negative regulation of ERK1 and ERK2 cascade; negative regulation of cell population proliferation; and negative regulation of cellular protein metabolic process. Predicted to be located in synapse. Implicated in ovarian cancer; ovarian carcinoma; and prostate adenocarcinoma. Biomarker of hepatocellular carcinoma; oral squamous cell carcinoma; prostate cancer; and thyroid gland papillary carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
CAMK2N1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_018584.6 | NP_061054.2 | calcium/calmodulin-dependent protein kinase II inhibitor 1 |
CAMK2N1 Protein Structure
CaM-KIIN: Calcium/calmodulin-dependent protein kinase II inhibitor (1 - 78)
- 0
- 78 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Mucinous Cystadenocarcinoma Of Pancreas |
|
|
| Oral Squamous Cell Carcinoma |
|
|
| Ovarian Cancer |
|
|
| Prostate Cancer |
|
|